Not logged in Share Save
Share Save
Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis (vol. 124, pg. 1069, 2014) Arjonen, Antti; Kaukonen, Riina; Mattila, Elina; Rouhi, Pegah; Hognas, Gunilla; Sihto, Harri; Miller, Bryan W.; Morton, Jennifer P.; Bucher, Elmar; Taimen, Pekka; Virtakoivu, Reetta; Cao, Yihai; Sansom, Owen J.; Joensuu, Heikki; Ivaska, Johanna Share Save
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP) Morgans, Alicia K.; Chehrazi-Raffle, Alex; Niazi, Tamim; Shore, Neal D.; Ross, Ashley E.; Roder, Andreas; Gomes, Andrea Juliana; Supiot, Stephane; Barthelemy, Philippe; Hatano, Koji; Ruiz, Carmen Belen Congregado; Yoshida, Soichiro; Herrera-Imbroda, Bernardo; Gratton, Matthieu; Gschwend, Jurgen E.; Hope, Thomas A.; Joensuu, Heikki; Kuss, Iris; Le Berre, Marie-Aude; Dimova-Dobreva, Miryana; Fizazi, Karim Share Save
Share Save
Drug-tolerant persisting polyploid giant cancer cells mediate resistance to HER2-targeting antibody-drug conjugates Yazdi, Narjes; Pourjamal, Negar; Katainen, Riku; Vaananen, Juho; Dai, Jun; Vaharautio, Anna; Isola, Jorma; Kempas, Minna; Le Joncour, Vadim; Laakkonen, Pirjo; Joensuu, Heikki; Barok, Mark Share Save
Share Save
Share Save
Share Save
PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer Azad, Abul; Arshad, Maryam; Generali, Daniele; Feldinger, Katharina; Gijsen, Merel; Strina, Carla; Cappelletti, Mariarosa; Andreis, Daniele; Leek, Russell; Haider, Syed; Kellokumpu-Lehtinen, Pirkko-Liisa; Roxanis, Ioannis; Harris, Adrian Llewellyn; Shaaban, Abeer Mahmoud; Joensuu, Heikki; Kong, Anthony Share Save
Share Save
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer A Secondary Analysis of the SOLD Randomized Clinical Trial Joensuu, Heikki; Fraser, Judith; Wildiers, Hans; Huovinen, Riikka; Auvinen, Paeivi; Utriainen, Meri; Villman, Kenneth K.; Halonen, Paivi; Granstam-Bjorneklett, Helena; Tanner, Minna; Sailas, Liisa; Turpeenniemi-Hujanen, Taina; Yachnin, Jeffrey; Huttunen, Teppo; Neven, Patrick; Canney, Peter; Harvey, Vernon J.; Kellokumpu-Lehtinen, Pirkko-Liisa; Lindman, Henrik Share Save
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial Joensuu, Heikki; Reichardt, Annette; Eriksson, Mikael; Hohenberger, Peter; Boye, Kjetil; Cameron, Silke; Lindner, Lars H.; Jost, Philipp J.; Bauer, Sebastian; Schuette, Jochen; Lindskog, Stefan; Kallio, Raija; Jaakkola, Panu M.; Goplen, Dorota; Wardelmann, Eva; Reichardt, Peter Share Save
The spatially resolved single-cell atlas of the tumor immune architecture revealed the central role of IFN-alpha and plasmacytoid dendritic cells in triple-negative breast cancer in the Mayo Clinic cohort and FinXX trial Chumsri, Saranya; Liu, Yi; Ma, Yaohua; Carter, Jodi; Gregory, Mark; Church, Sarah; Reeves, Jason; Brauer, Heather Ann; Warren, Sarah; Joensuu, Heikki; Perez, Edith; Leon-Ferre, Roberto; Hillman, David; Boughey, Judy; Ingle, James; Kalari, Krishna; Couch, Fergus; Goetz, Matthew; Knutson, Keith; Thompson, E. Share Save
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model Pourjamal, Negar; Yazdi, Narjes; Halme, Aleksi; Le Joncour, Vadim; Laakkonen, Pirjo; Saharinen, Pipsa; Joensuu, Heikki; Barok, Mark Share Save
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer Jones, Robert Hugh; Fizazi, Karim; James, Nicholas D.; Tammela, Teuvo L.; Matsubara, Nobuaki; Priou, Frank; Beuzeboc, Philippe; Lesimple, Thierry; Bono, Petri; Kataja, Vesa; Garcia, Jorge A.; Protheroe, Andrew; Shore, Neal; Aspegren, John; Joensuu, Heikki; Kuss, Iris; Fiala-Buskies, Sabine; Vjaters, Egils Share Save
Genome-Wide Association Study Identifies 4 Novel Risk Loci for Small Intestinal Neuroendocrine Tumors Including a Missense Mutation in LGR5 Giri, Anil K.; Aavikko, Mervi; Wartiovaara, Linnea; Lemmetyinen, Toni; Karjalainen, Juha; Mehtonen, Juha; Palin, Kimmo; Valimaki, Niko; Tamlander, Max; Saikkonen, Riikka; Karhu, Auli; Morgunova, Ekaterina; Sun, Benjamin; Runz, Heiko; Palta, Priit; Luo, Shuang; Joensuu, Heikki; Makela, Tomi P.; Kostiainen, Iiro; Schalin-Jantti, Camilla; FinnGen; Palotie, Aarno; Aaltonen, Lauri A.; Ollila, Saara; Daly, Mark J. Share Save
Darolutamide plus androgen-deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: A phase III, randomized, double-blind, placebo-controlled study (ARASTEP) Morgans, A. K.; Gschwend, J. E.; Shore, N. D.; Ross, A.; Feng, F.; Hope, T.; Trandafir, L.; Le Berre, M-A.; Kuss, I.; Joensuu, H.; Fizazi, K. Share Save
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer Carter, Jodi M.; Chumsri, Saranya; Hinerfeld, Douglas A.; Ma, Yaohua; Wang, Xue; Zahrieh, David; Hillman, David W.; Tenner, Kathleen S.; Kachergus, Jennifer M.; Brauer, Heather Ann; Warren, Sarah E.; Henderson, David; Shi, Ji; Liu, Yi; Joensuu, Heikki; Lindman, Henrik; Leon-Ferre, Roberto A.; Boughey, Judy C.; Liu, Minetta C.; Ingle, James N.; Kalari, Krishna R.; Couch, Fergus J.; Knutson, Keith L.; Goetz, Matthew P.; Perez, Edith A.; Thompson, E. Aubrey Share Save
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial Joensuu, Heikki; Wardelmann, Eva; Eriksson, Mikael; Reichardt, Annette; Hall, Kirsten Sundby; Schuette, Jochen; Cameron, Silke; Hohenberger, Peter; Sihto, Harri; Jost, Philipp J.; Lindner, Lars H.; Bauer, Sebastian; Nilsson, Bengt; Kallio, Raija; Pesonen, Tommi; Reichardt, Peter Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
